At the heart of the case for so-called “gender-affirming care” is the claim that transition prevents suicide. Research, however, shows the opposite. In a summary of recent research, Ben Johnson described how life satisfaction among those who undergo “transition” surgeries decreases rather than increases. 

While activists in the U.S. seek to eliminate any restrictions to so-called “gender-affirming” interventions for minors, a number of European countries are adding safeguards around or backing off altogether from these controversial procedures. Following European neighbors Finland, Sweden, and the United Kingdom, the Norwegian Healthcare Investigation Board announced that it will revise its recommended standards of care for minors struggling with gender dysphoria. The proposed revisions would no longer allow the use of puberty blockers, cross-sex hormones, and transition surgery for minors. 

As NHIB rightfully points out, the science surrounding “gender-affirming care” is far from settled. In fact, the use of puberty blockers, cross-sex hormones, or transition surgeries to treat gender dysphoria lacks adequate research. There is hardly any substantial research on the long-term effects of these treatments on minors, and what we do know about them is disregarded by ideologically driven proponents. Puberty blockers, for example, have been known to plague patients with loss of bone density. Cross-sex hormones lead to sterilization. Transition surgeries are rife with serious complications. In the name of a dubious ideology, we’re experimenting on children. 

Additionally, most of the long-term studies that proponents cite to support current “gendering-affirming” protocols are poorly designed. As the report summarized: “As a rule, there is no control group in the studies.” This means that any effects are “often assessed at group level and not at individual level, so that unwanted effects for some patients can be masked by improvement in the rest of the group.”

Read More